NCT03022721

Heidelberg Study on Diabetes and Complications

Name: Clinical Trial NCT03022721
Creator: Heidelberg University
Keywords: Diabetes Complications, No interventions are planned for this study., other, clinical trial, Germany

Heidelberg University·ClinicalTrials.gov·otherRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Diabetes Complications
Drug/Device/Intervention: No interventions are planned for this study.
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: Heidelberg University
Location: Heidelberg, Germany

Timeline & enrollment

Phase: N/A
Start date: Sep 01, 2016
End date: Sep 01, 2028
Enrollment: 500 participants

Primary outcome

Development of diabetic complications

Summary

The prospective observational study entitled Heidelberg Study on Diabetes and Complications is designed to Monitor the presence and development of diabetic complications in type 1 and type 2 diabetic patients, as well as pre-diabetics. Mail Goal is to detect new metabolic mechanisms or new risk factors for the development of diabetic complications in order to identify risk-subgroups. Non-diabetic controls will be enrolled for reference and comparison.

ICD-10 classifications

Unspecified diabetes mellitus without complicationsOther specified diabetes mellitus with other specified complicationsOther specified diabetes mellitus without complicationsUnspecified diabetes mellitus with other specified complicationsOther specified diabetes mellitus with unspecified complications

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT03022721
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT03022721 through Pure Global AI's free database. This phase not specified trial is sponsored by Heidelberg University and is currently Recruiting. The study focuses on Diabetes Complications. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.